Frank Kroschinsky

Allogeneic stem cell transplantation for major T-cell lymphoma entities: an analysis of the EBMT-lymphoma working party

Synthetic bone marrow images augment real samples in developing acute myeloid leukemia microscopy classification models

Image-based explainable artificial intelligence accurately identifies myelodysplastic neoplasms beyond conventional signs of dysplasia

Granulocyte Colony Stimulating Factor (G‐<scp>CSF</scp>) and Olfactory Function—A Clinical Pilot Study

High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trial

Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome

Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles

CONSOLIDATIVE HCT‐ASCT IS SUPERIOR TO NON‐MYELOABLATIVE CHEMO‐IMMUNOTHERAPY IN NEWLY‐DIAGNOSED PCNSL ‐ UPDATED RESULTS OF THE RANDOMIZED PHASE III MATRIX/IELSG43 TRIAL

Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smears

Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations

Prevalence and variation of CHIP in patients with aggressive lymphomas undergoing CD19-directed CAR T-cell treatment

Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning

Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43)

Deep learning detects acute myeloid leukemia and predicts NPM1 mutation status from bone marrow smears

Clonal hematopoiesis and its emerging effects on cellular therapies

Comparison of five diagnostic flow cytometry scores in patients with myelodysplastic syndromes: Diagnostic power and prognostic impact

Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury

Loss-of-Function Mutations of BCOR Are an Independent Marker of Adverse Outcomes in Intensively Treated Patients with Acute Myeloid Leukemia

Prediction of Complete Remission and Survival in Acute Myeloid Leukemia Using Supervised Machine Learning

A randomized phase 3 trial of auto vs. allo transplantation as part of first-line therapy in poor-risk peripheral T-NHL

Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial

First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A—results of a retrospective analysis

Consensus statement for cancer patients requiring intensive care support

Differences in Cellular Composition of Peripheral Blood Stem Cell Grafts from Healthy Stem Cell Donors Mobilized with Either Granulocyte Colony-Stimulating Factor (G-CSF) Alone or G-CSF and Plerixafor

New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas – a Randomized Controlled Trial Comparing Different Treatment Approaches Based on Interim PET Results (PETAL Trial)

Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT